Sarah Cannon Research Institute London

London, England W1G6AD

1 studies enrolling now · 4 studies all time

What they study most

Advanced Melanoma, Advanced Solid Tumor, Bladder Cancer, Cervical Carcinoma, Cervix Cancer, Endometrium Cancer, Esophagus Cancer, Lung Cancer(NSCLC), Ovary Cancer, Prostate Cancer (CRPC), Solid Tumor, Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Studies at this site

• A Study of PYX-201 in Advanced Solid Tumors — Recruiting now
• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. — Recruiting now
• Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma — Stopped early
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors — Completed